image

The best stocks to buy since 1993

Latest issue now available

Regenersis

August 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RGS
  • Price:
  • 169p
Ahead of reporting on 22 September, Regenersis has said profit for the year just ended will be in line with expectations (eps 17.3p).Regenersis’ repair side achieved growth in revenue and headline operating profit. However, post the year end, it has lost a key customer, Microsoft/Nokia (worth c.£25m annual sales).  Microsoft of course owns Nokia and has also just unveiled its own biggest loss in history, with a US$7bn writedown of the mobile technology business it bought only in 2014. So far, Regenersis has only lost Microsoft/Nokia in Europe and the worry is that it does have exposure to the customer elsewhere.Blancco, the data erasure business, has seen sales grow by 27% in its first full year as part of th ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe